This inventor holds 2 USPTO granted patents. Top assignee: St. Jude Children's Research Hospital. Active years: 1998-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2002
Title: Nicolai V Kaverin: Innovator in Influenza Vaccine Development
Introduction
Nicolai V Kaverin is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of virology, particularly in the development of influenza vaccines. With a total of 2 patents, Kaverin's work focuses on enhancing the replication of influenza viruses for vaccine production.
Latest Patents
Kaverin's latest patents include innovative methods for replicating high growth influenza virus strains in mammalian cell cultures. The first patent details a process that involves infecting mammalian cells with high growth strains derived from clinical isolates. This method allows for the cultivation of infected cells while maintaining a trypsin concentration range of 0.05-1.0 µg/ml in the culture medium. The resulting replicated virus is suitable for use in mammalian influenza vaccines and vaccination methods. The second patent reiterates this process, emphasizing its importance in producing effective vaccines against influenza.
Career Highlights
Kaverin is affiliated with St. Jude Children's Research Hospital, where he continues to advance research in the field of infectious diseases. His work has been instrumental in developing new strategies for vaccine production, which are crucial for public health.
Collaborations
Kaverin collaborates with notable figures in the field, including Robert G Webster, who is also recognized for his contributions to influenza research.
Conclusion
Nicolai V Kaverin's innovative work in influenza vaccine development showcases his commitment to improving public health through scientific research. His patents reflect a significant advancement in the replication of influenza viruses, paving the way for more effective vaccines.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
